Rumeng Zhang
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multiomics analysis of homologous recombination deficiency across cancer types.
Journal: Biomolecules & biomedicine
Published: March 07, 2024
CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma.
Journal: Biomolecules & biomedicine
Published: February 20, 2024
EVALUATION OF PRE-ABLATION NLR AND LMR AS PREDICTORS OF DISTANT METASTASES IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
Journal: Acta endocrinologica (Bucharest, Romania : 2005)
Published: November 01, 2023
Corrigendum: NUDT21 promotes tumor growth and metastasis through modulating SGPP2 in human gastric cancer.
Journal: Frontiers in oncology
Published: June 14, 2023
The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
Journal: Frontiers in immunology
Published: March 07, 2023
Multiomics analysis of tumor mutational burden across cancer types.
Journal: Computational and structural biotechnology journal
Published: June 22, 2021
NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer.
Journal: Frontiers in oncology
Published: February 21, 2021
A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo.
Journal: Frontiers in oncology
Published: February 18, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026